C S Matthews Selected Research

Neoplasms (Cancer)

1/2006	DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers.
4/2001	Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C S Matthews Research Topics

Disease

2	Neoplasms (Cancer) 01/2006 - 04/2001
1	Breast Neoplasms (Breast Cancer) 07/2000

Drug/Important Bio-Agent (IBA)

1	EnzymesIBA 01/2006
1	ImmunosorbentsIBA 01/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2001
1	2-(4-aminophenyl)benzothiazoleIBA 07/2000
1	NSC 674495IBA 07/2000